Azar Baradaran
1,2 
, Padideh Daneii
3 , Mahshid Imankhan
4 , Mahsa Motieian
5 , Sina Neshat
6* 1 Department of Pathology, Al-Zahra Hospital, Isfahan, Iran
2 Nickan Research Institute, Isfahan, Iran
3 Department of Cardiology, University of Florida Health, Jacksonville, Florida, United States
4 Independent Researcher, 1514 Sheridan Rd NE apt 4014, Atlanta, Georgia, United States
5 Independent Researcher, Dobbs Ferry, New York, United States
6 Department of Biostatistics and Epidemiology, 550 16th St, University of California San Francisco, San Francisco, CA, United States
Abstract
Prospects in parathyroid diseases involve a multidisciplinary approach that combines research, clinical practice, and patient-centered care to improve understanding, diagnosis, and treatment outcomes for individuals with these conditions. Accordingly, further advancements in genetics, biomarkers, imaging, targeted therapies, non-surgical treatments, and personalized medicine can potentially revolutionize diagnosing, treating, and managing parathyroid diseases.